Publications by authors named "F Rubbi"

Nanofluids are identified as advanced working fluids in the solar energy conversion field with superior heat transfer characteristics. This research work introduces carbon-based diamond nanomaterial and Therminol55 oil-based nanofluids for implementation in a concentrated photovoltaic/thermal (CPV/T) solar collector. This study focuses on the experimental formulation, characterization of properties, and performance evaluation of the nanofluid-based CPV/T system.

View Article and Find Full Text PDF

In recent years, solar energy technologies have developed an emerging edge. The incessant research to develop a power source alternative to fossil fuel because of its scarcity and detrimental effects on the environment is the main driving force. In addition, nanofluids have gained immense interest as superior heat transfer fluid in solar technologies for the last decades.

View Article and Find Full Text PDF

Objective: To compare the effect of the prepubertal duration of diabetes on the occurrence of complications in two groups of patients after the same number of years of the disease.

Research Design And Methods: This multicenter study enrolled 105 patients aged 16-40.3 years; 53 were prepubertal at diagnosis (aged 0-3) and 52 were pubertal (Tanner stage) and aged 9-14.

View Article and Find Full Text PDF

Introduction: Retinal vein occlusion (RVO) is a common cause of unilateral visual loss. Evidence based treatment recommendations for patients with RVO cannot be made because of the lack of adequate clinical trials. To compare the efficacy and safety of aspirin and of a low molecular weight heparin, parnaparin, in the treatment of RVO.

View Article and Find Full Text PDF

Background: Little is known about minimal retinal lesions occurring in the first months of disease in children with type 1 diabetes mellitus (DM).

Objective: To detect any early retinal change and to evaluate its progression in children diagnosed with type 1 DM.

Patients: From 1979 to 1997 we examined by fluorescein angiography at diagnosis or within 15 months from the onset of DM 130 young patients with type 1 DM (mean age at diagnosis 10.

View Article and Find Full Text PDF